Newsletter
Semaglutide for Weight Loss, Ivermectin for Mild COVID-19, USPSTF Guideline on Screening for Vitamin D Deficiency, and more

JAMA Editor’s Summary

Semaglutide for Weight Loss, Ivermectin for Mild COVID-19, USPSTF Guideline on Screening for Vitamin D Deficiency, and more

Editor's Summary by Anne Cappola, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the
April 13, 2021
ADVERTISEMENT

Newer →

Poloxamer 188 for Sickle Cell Disease, CDC Recommendations for Fully Vaccinated People, Oral Antiplatelet Therapy for ACS, and more

← Older

Low- vs High-Intensity Walking for PAD, Celecoxib for Stage III CRC, N95 Reprocessing Review, and more
Buffer LinkedIn WhatsApp

Semaglutide for Weight Loss, Ivermectin for Mild COVID-19, USPSTF Guideline on Screening for Vitamin D Deficiency, and more

Editor’s Summary by Anne Cappola, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the April 13, 2021 issue

ADVERTISEMENT
ADVERTISEMENT

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Silver Sponsors

Bronze Sponsors

Event and Media Partners

Buffer LinkedIn WhatsApp
00:00
00:00